Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer

    NEXT STORY
    Global Pediatric Vaccine Market Will Reach to USD 56.28 Billion By 2025: Zion Market Research
    PREV STORY
    iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Amid the COVID-19 crisis and the looming economic recession, the Nanotechnology in Drug Delivery market worldwide will grow by a projected US$124.7 Billion, during the analysis period

    author_avatar
    NASDAQ Market News

    Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic

    ZIKV-IG granted Fast Track designation by the U.S. Food and Drug AdministrationGAITHERSBURG, Md., July ...

    author_avatar
    NASDAQ Market News

    Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance

    author_avatar
    NASDAQ Market News